Literature DB >> 21835781

The experiences of cancer patients.

C Alifrangis1, L Koizia, A Rozario, S Rodney, M Harrington, C Somerville, T Peplow, J Waxman.   

Abstract

OBJECTIVES: To assess the needs of cancer patients for information about their condition and to understand the psychological impact of their illness.
BACKGROUND: The discussion of prognosis and treatment options in the palliative setting is an important and difficult part of oncology practice. To evaluate this, we examined the experiences of cancer patients of the physical and psychological impact of their disease on their life, and their opinions on the communication of end-of-life decisions and treatment options.
METHODS: A patient questionnaire was designed that encompassed communication regarding treatment and prognosis, quality-of-life attitudes subsequent to cancer diagnosis, end-of-life care and cancer drug funding. One hundred and twenty-five patients with a diagnosis of cancer were asked to participate and 96 questionnaires were completed and available for analysis. The questionnaire consisted of 63 questions and was completed in both an inpatient and outpatient setting.
RESULTS: This survey brought to light a number of controversial issues in cancer service provision, highlighting the emotional and psychological changes brought about by a cancer diagnosis. Major concerns of our patients include fear of death and pain, changes in interpersonal relationships and financial constraints. Only 66% of the patients wanted to be given a prognosis by their clinicians and just 70% of the patients recalled being given a detailed prognosis. 11% of the patients were not prepared to undergo palliative treatment. In all, 7% were not prepared to accept treatment for 1 year and 2% for 5 years of life in exchange for the potential side effects of cytotoxic chemotherapy. 12% of the patients would not want to be in possession of the information that they were in the terminal phase of the illness with a short time to live and 16% would not want this discussed with their next of kin.
CONCLUSION: This study informs medical professionals about the importance of tailoring information to the needs of the individual patient, and we feel it provides insights into the successes and failures of our communication with cancer patients. It is important that difficult discussions are personalized to the individual patients' wishes. These can vary dramatically both in the area of disclosure of bad news in prognosis and in end-of-life decision making. This study provides compelling evidence for good advanced care planning at an early stage in the management of patients with terminal cancers.

Entities:  

Mesh:

Year:  2011        PMID: 21835781     DOI: 10.1093/qjmed/hcr129

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system.

Authors:  Paul A Fishman; Mark C Hornbrook; Debra P Ritzwoller; Maureen C O'Keeffe-Rosetti; Jennifer Elston Lafata; Ramzi G Salloum
Journal:  J Natl Cancer Inst Monogr       Date:  2013

2.  The Developmental Transition From Living With to Dying From Cancer: Hospice Decision Making.

Authors:  Deborah Waldrop; Mary Ann Meeker; Jean S Kutner
Journal:  J Psychosoc Oncol       Date:  2015

3.  Evaluation of a Nurse-Delivered Pre-Chemotherapy Educational Intervention to Increase Knowledge and Reduce Anxiety Among Ethnically Diverse Patients.

Authors:  Sarah E Piombo; Kimberly A Miller; Kaitlin Alderete; Alden Egan; Sally Golingay; Thomas W Valente
Journal:  J Cancer Educ       Date:  2021-08       Impact factor: 2.037

4.  Magnitude of score change for the palliative prognostic index for survival prediction in patients with poor prognostic terminal cancer.

Authors:  Chia-Yen Hung; Hung-Ming Wang; Chen-Yi Kao; Yung-Chang Lin; Jen-Shi Chen; Yu-Shin Hung; Wen-Chi Chou
Journal:  Support Care Cancer       Date:  2014-05-06       Impact factor: 3.603

5.  Clinical characteristics of cancer patients referred early to supportive and palliative care.

Authors:  Jung Hye Kwon; David Hui; Gary Chisholm; Caroline Ha; Sriram Yennurajalingam; Jung Hun Kang; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-01-18       Impact factor: 2.947

Review 6.  A systematic review of barriers to optimal outpatient specialist services for individuals with prevalent chronic diseases: what are the unique and common barriers experienced by patients in high income countries?

Authors:  Elizabeth A Fradgley; Christine L Paul; Jamie Bryant
Journal:  Int J Equity Health       Date:  2015-06-09

7.  Arctium lappa Extract Suppresses Inflammation and Inhibits Melanoma Progression.

Authors:  Bruno A C Nascimento; Luiz G Gardinassi; Inaê M G Silveira; Marília G Gallucci; Mariana A Tomé; Júlia Fernanda D Oliveira; Mirella R A Moreira; Alyne F G Meirelles; Lúcia H Faccioli; Cristiane Tefé-Silva; Karina F Zoccal
Journal:  Medicines (Basel)       Date:  2019-07-29

8.  Curcumol inhibits the proliferation and metastasis of melanoma via the miR-152-3p/PI3K/AKT and ERK/NF-κB signaling pathways.

Authors:  Ning Ning; Sulai Liu; Xiehong Liu; Zeyu Tian; Yu Jiang; Nanhui Yu; Boyu Tan; Hao Feng; Xing Feng; Lianhong Zou
Journal:  J Cancer       Date:  2020-01-14       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.